ID
21925
Description
The present pharmacokinetic study is designed to assess the pharmacokinetics of RSG XR as monotherapy in patients with mild Alzheimer's disease (AD) as such information will not be obtained from the current phase III trials . The study aims to enroll fourteen patients (seven of each APOE genotype). Each patient will receive a single oral dose of 4mg of RSG XR in the morning under fasted conditions and PK samples will be taken up to 36h. GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00688207?term=NCT00688207&rank=1
Keywords
Versions (2)
- 5/8/17 5/8/17 -
- 5/20/17 5/20/17 -
Uploaded on
May 8, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
Description
Medication
Alias
- UMLS CUI-1
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Description
Drug name
Data type
text
Alias
- UMLS CUI [1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Description
Unit Dose
Data type
float
Alias
- UMLS CUI [1]
- C0869039 (Unit dose)
- SNOMED
- 408102007
Description
Units
Data type
text
Alias
- UMLS CUI [1]
- C1519795 (Unit of Measure)
- SNOMED
- 767524001
Description
Frequency
Data type
text
Alias
- UMLS CUI [1]
- C3476109 (Medication frequency)
- LOINC
- LP149758-7
Description
Route
Data type
text
Alias
- UMLS CUI [1]
- C0013153 (Drug Administration Routes)
- SNOMED
- 410675002
- LOINC
- LP40261-7
Description
Reason for Medication
Data type
text
Alias
- UMLS CUI [1,1]
- C0392360 (Indication of (contextual qualifier))
- SNOMED
- 230165009
- LOINC
- MTHU008319
- UMLS CUI [1,2]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
Description
Start Date
Data type
date
Alias
- UMLS CUI [1]
- C0808070 (Start Date)
Description
Start time
Data type
time
Measurement units
- hh:min
Alias
- UMLS CUI [1]
- C1301880 (Start time)
- SNOMED
- 398201009
- LOINC
- LP102339-1
Description
Taken Prior to Study
Data type
boolean
Alias
- UMLS CUI [1]
- C2826667 (Concomitant Medication Previous Occurrence)
Description
Stop Date
Data type
date
Alias
- UMLS CUI [1]
- C0806020 (End date)
- SNOMED
- 454551000124105
- LOINC
- MTHU008302
Description
Stop Time
Data type
time
Alias
- UMLS CUI [1]
- C1522314 (End Time)
- SNOMED
- 397898000
Description
Ongoing Medication
Data type
boolean
Alias
- UMLS CUI [1]
- C2826666 (Concomitant Medication Ongoing)
Similar models
Concomitant Medications Mild Alzheimer's Disease to Assess the of Extended Release Formulation of Rosiglitazone NCT00688207 / GSK-AVA109941
C0013227 (UMLS CUI [1,2])
No comments